In our study, we aimed at assessing the usefulness of glycyrrhizin for the treatment of murine experimentally-induced colitis by examining a wider range of molecular and morphological end-points and highlighting the close relation between glycyrrhizin efficacy and HMGB1 reduced activity. This evidence concerns the gene HMGB1 and colitis.